High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning.

MLA

McDonnell, Martin, et al. “High Incidence of Glucocorticoid-Induced Hyperglycaemia in Inflammatory Bowel Disease: Metabolic and Clinical Predictors Identified by Machine Learning.” BMJ Open Gastroenterology, vol. 7, no. 1, Nov. 2020. EBSCOhost, https://doi.org/10.1136/bmjgast-2020-000532.

APA

McDonnell, M., Harris, R. J., Borca, F., Mills, T., Downey, L., Dharmasiri, S., Patel, M., Zare, B., Stammers, M., Smith, T. R., Felwick, R., Cummings, J. R. F., Phan, H. T. T., & Gwiggner, M. (2020). High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning. BMJ Open Gastroenterology, 7(1). https://doi.org/10.1136/bmjgast-2020-000532

Chicago

McDonnell, Martin, Richard J Harris, Florina Borca, Tilly Mills, Louise Downey, Suranga Dharmasiri, Mayank Patel, et al. 2020. “High Incidence of Glucocorticoid-Induced Hyperglycaemia in Inflammatory Bowel Disease: Metabolic and Clinical Predictors Identified by Machine Learning.” BMJ Open Gastroenterology 7 (1). doi:10.1136/bmjgast-2020-000532.